Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Coca-Cola Company stock logo
KO
Coca-Cola
$71.85
+0.3%
$68.14
$57.93
$73.53
$309.21B0.5714.94 million shs15.30 million shs
Realty Income Co. stock logo
O
Realty Income
$57.15
-1.5%
$55.90
$50.65
$64.88
$50.95B15.15 million shs5.13 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.53
-3.2%
$26.00
$24.48
$31.54
$139.09B0.6139.21 million shs54.33 million shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Coca-Cola Company stock logo
KO
Coca-Cola
+1.88%+3.94%+0.69%+15.14%+17.17%
Realty Income Co. stock logo
O
Realty Income
+2.56%+3.09%+1.80%+8.70%+7.31%
Pfizer Inc. stock logo
PFE
Pfizer
+0.61%-2.98%-4.07%-4.43%-8.63%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Coca-Cola Company stock logo
KO
Coca-Cola
4.1298 of 5 stars
2.53.03.30.83.42.51.3
Realty Income Co. stock logo
O
Realty Income
3.6139 of 5 stars
2.14.02.51.72.81.70.6
Pfizer Inc. stock logo
PFE
Pfizer
4.9817 of 5 stars
3.33.04.24.22.73.33.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Coca-Cola Company stock logo
KO
Coca-Cola
3.00
Buy$74.243.32% Upside
Realty Income Co. stock logo
O
Realty Income
2.21
Hold$62.048.56% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.63
Moderate Buy$31.9230.17% Upside

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/18/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/4/2025
Realty Income Co. stock logo
O
Realty Income
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $59.00
2/28/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$73.00 ➝ $80.00
2/28/2025
Realty Income Co. stock logo
O
Realty Income
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$59.00 ➝ $57.00
2/26/2025
Realty Income Co. stock logo
O
Realty Income
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$62.00 ➝ $60.00
2/25/2025
Realty Income Co. stock logo
O
Realty Income
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$61.00
2/13/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$66.00 ➝ $73.00
2/13/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$75.00
2/12/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$72.00 ➝ $78.00
(Data available from 4/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Coca-Cola Company stock logo
KO
Coca-Cola
$47.06B6.57$3.22 per share22.29$6.12 per share11.74
Realty Income Co. stock logo
O
Realty Income
$5.27B9.67$3.84 per share14.90$45.73 per share1.25
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.19$3.84 per share6.38$15.81 per share1.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Coca-Cola Company stock logo
KO
Coca-Cola
$10.63B$2.4729.0922.523.7922.59%45.37%12.24%4/29/2025 (Estimated)
Realty Income Co. stock logo
O
Realty Income
$872.31M$0.9854.4313.232.1017.57%2.35%1.34%5/5/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4117.398.090.6412.62%19.47%8.09%4/29/2025 (Estimated)

Latest KO, O, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2025N/A
The Coca-Cola Company stock logo
KO
Coca-Cola
$0.72N/AN/AN/A$11.23 billionN/A
2/24/2025Q4 2024
Realty Income Co. stock logo
O
Realty Income
$1.06$1.05-$0.01$1.05$1.28 billion$1.34 billion
2/11/2025Q4 2024
The Coca-Cola Company stock logo
KO
Coca-Cola
$0.51$0.55+$0.04$0.51$10.70 billionN/A
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Coca-Cola Company stock logo
KO
Coca-Cola
$2.042.84%+4.91%82.59%64 Years
Realty Income Co. stock logo
O
Realty Income
$3.225.63%-3.64%328.57%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.01%+2.50%121.99%16 Years

Latest KO, O, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/12/2025
Realty Income Co. stock logo
O
Realty Income
apr 25$0.26855.7%4/1/20254/1/20254/15/2025
2/20/2025
The Coca-Cola Company stock logo
KO
Coca-Cola
quarterly$0.512.9%3/14/20253/14/20254/1/2025
2/19/2025
Realty Income Co. stock logo
O
Realty Income
mar 25$0.26805.7%3/3/20253/3/20253/14/2025
1/14/2025
Realty Income Co. stock logo
O
Realty Income
feb 25$0.26405.9%2/3/20252/3/20252/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Coca-Cola Company stock logo
KO
Coca-Cola
1.61
1.03
0.84
Realty Income Co. stock logo
O
Realty Income
0.68
1.40
1.40
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73

Institutional Ownership

CompanyInstitutional Ownership
The Coca-Cola Company stock logo
KO
Coca-Cola
70.26%
Realty Income Co. stock logo
O
Realty Income
70.81%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
The Coca-Cola Company stock logo
KO
Coca-Cola
0.97%
Realty Income Co. stock logo
O
Realty Income
0.10%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Coca-Cola Company stock logo
KO
Coca-Cola
82,5004.30 billion4.27 billionOptionable
Realty Income Co. stock logo
O
Realty Income
400891.52 million874.34 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
83,0005.67 billion5.66 billionOptionable

Recent News About These Companies

Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Shares Down 1.5% - Here's Why
EC amends authorization for Pfizer’s RSV vaccine Abrysvo

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Coca-Cola stock logo

Coca-Cola NYSE:KO

$71.85 +0.23 (+0.32%)
Closing price 03:59 PM Eastern
Extended Trading
$71.86 +0.02 (+0.02%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Realty Income stock logo

Realty Income NYSE:O

$57.15 -0.86 (-1.48%)
Closing price 03:59 PM Eastern
Extended Trading
$57.14 -0.01 (-0.02%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O).

Pfizer stock logo

Pfizer NYSE:PFE

$24.52 -0.82 (-3.22%)
Closing price 03:59 PM Eastern
Extended Trading
$24.61 +0.09 (+0.35%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.